Erin L. Reineke, Ph.D. - Publications

2008 Case Western Reserve University, Cleveland Heights, OH, United States 
Biochemistry, Oncology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 York B, Sagen JV, Tsimelzon A, Louet JF, Chopra AR, Reineke EL, Zhou S, Stevens RD, Wenner BR, Ilkayeva O, Bain JR, Xu J, Hilsenbeck SG, Newgard CB, O'Malley BW. Research resource: tissue- and pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) family. Molecular Endocrinology (Baltimore, Md.). 27: 366-80. PMID 23315938 DOI: 10.1210/me.2012-1324  0.96
2012 Reineke EL, York B, Stashi E, Chen X, Tsimelzon A, Xu J, Newgard CB, Taffet GE, Taegtmeyer H, Entman ML, O'Malley BW. SRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heart. Plos One. 7: e53395. PMID 23300926 DOI: 10.1371/journal.pone.0053395  0.96
2012 York B, Reineke EL, Sagen JV, Nikolai BC, Zhou S, Louet JF, Chopra AR, Chen X, Reed G, Noebels J, Adesina AM, Yu H, Wong LJ, Tsimelzon A, Hilsenbeck S, et al. Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy. Cell Metabolism. 15: 752-63. PMID 22560224 DOI: 10.1016/j.cmet.2012.03.020  0.96
2012 O'Donnell KA, Keng VW, York B, Reineke EL, Seo D, Fan D, Silverstein KA, Schrum CT, Xie WR, Mularoni L, Wheelan SJ, Torbenson MS, O'Malley BW, Largaespada DA, Boeke JD. A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: E1377-86. PMID 22556267 DOI: 10.1073/pnas.1115433109  0.96
2010 Reineke EL, Liu Y, Kao HY. Promyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-like growth factor-1. The Journal of Biological Chemistry. 285: 9485-92. PMID 20100838 DOI: 10.1074/jbc.M109.063362  0.96
2009 Reineke EL, Kao HY. PML: An emerging tumor suppressor and a target with therapeutic potential. Cancer Therapy. 7: 219-226. PMID 19756257  0.96
2009 Reineke EL, Kao HY. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies. International Journal of Biological Sciences. 5: 366-76. PMID 19471587  0.96
2008 Reineke EL, Lam M, Liu Q, Liu Y, Stanya KJ, Chang KS, Means AR, Kao HY. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells. Molecular and Cellular Biology. 28: 997-1006. PMID 18039859 DOI: 10.1128/MCB.01848-07  0.96
2007 Reineke EL, Liu H, Lam M, Liu Y, Kao HY. Aberrant association of promyelocytic leukemia protein-retinoic acid receptor-alpha with coactivators contributes to its ability to regulate gene expression. The Journal of Biological Chemistry. 282: 18584-96. PMID 17475621 DOI: 10.1074/jbc.M700330200  0.96
2006 Chakraborty S, Reineke EL, Lam M, Li X, Liu Y, Gao C, Khurana S, Kao HY. Alpha-actinin 4 potentiates myocyte enhancer factor-2 transcription activity by antagonizing histone deacetylase 7. The Journal of Biological Chemistry. 281: 35070-80. PMID 16980305 DOI: 10.1074/jbc.M602474200  0.96
2004 Liu H, Shaw CK, Reineke EL, Liu Y, Kao HY. Retinoid X receptor alpha (RXRalpha) helix 12 plays an inhibitory role in the recruitment of the p160 co-activators by unliganded RXRalpha/retinoic acid receptor alpha heterodimers. The Journal of Biological Chemistry. 279: 45208-18. PMID 15310754 DOI: 10.1074/jbc.M408033200  0.96
Show low-probability matches.